Revista de Nefrologia Dialisis y Trasplante (ISSN: 0326-3428; E-ISSN: 2346-8548) is a prominent open-access journal published by the ASOC REGIONAL DIALISIS TRASPLANTES RENALES since 2013, located in Buenos Aires, Argentina. This journal serves as a vital platform for the dissemination of pivotal research findings in the fields of nephrology and transplantation, covering a wide range of topics including clinical practices, patient outcomes, and innovative therapies. Although currently ranked in the Q4 category in both Nephrology and Transplantation by Scopus, the journal aims to elevate the discourse within these scientific communities by providing accessible and high-quality research to professionals and researchers alike. With its commitment to advancing knowledge and fostering collaboration among scientists, practitioners, and students, the Revista de Nefrologia Dialisis y Trasplante plays an essential role in addressing the critical challenges and developments in kidney health and organ transplantation.

CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION is a premier academic journal published by Lippincott Williams & Wilkins, focusing on the latest advancements and research in the fields of nephrology and hypertension. Since its inception in 1992, this journal has been an essential resource for professionals seeking to stay at the forefront of kidney health and blood pressure management. With a distinguished ranking in the top quartile (Q1) for both Internal Medicine and Nephrology as of 2023, the journal is recognized for its high impact, currently holding a Scopus rank of #16 out of 81 in Nephrology, positioning it in the 80th percentile. Although not an open access journal, it provides crucial insights and expert opinions that cater to researchers, clinicians, and students committed to improving patient outcomes through evidence-based practice. The journal continues to emphasize its objectives of disseminating pivotal findings and fostering discussions that bridge the gap between clinical practice and research, making it an invaluable asset in the evolving landscape of nephrology and hypertension.

Nephrologie, published by Springer Heidelberg, is a vital addition to the field of nephrology, providing a dedicated platform for the dissemination of cutting-edge research and clinical practices in kidney health. With its ISSN 2731-7463 and E-ISSN 2731-7471, this journal facilitates open access to a range of articles aimed at enhancing understanding and treatment of renal disorders. Located in Germany, Nephrologie is recognized for its commitment to advancing nephrological knowledge despite being currently categorized in the Q4 quartile and holding a Scopus rank of #80/81 within its field, indicating its emerging potential in the academic landscape. Operating from Tiergartenstraße 17, D-69121 Heidelberg, Germany, the journal encompasses a diverse scope that includes original research, review articles, and clinical studies, fostering a collaborative environment among researchers, healthcare professionals, and students. As it converges between 2022 and 2024, Nephrologie positions itself as a crucial resource for those committed to improving renal patient care and outcomes.

JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, published by SAGE PUBLICATIONS INC, stands as a vital resource in the fields of Endocrinology and Internal Medicine. With an impressive open access model established in 2014, this journal facilitates broad dissemination of high-quality research that explores the complex mechanisms and clinical implications of the renin-angiotensin-aldosterone system (RAAS). Currently, it is recognized within the 2023 Category Quartiles as Q3 in Endocrinology and Q2 in Internal Medicine, reflecting its significant impact on the scientific community. The journal ranks in the 75th percentile for Internal Medicine and the 57th percentile in Endocrinology according to Scopus, indicating its strong contributions to these disciplines. Covering a rich history from its inception in 2000 to the present, the journal aims to bridge the gap between basic research and clinical practice, thereby enhancing the understanding and treatment of conditions influenced by RAAS. The continuous publication of innovative research makes it an essential reference for researchers, healthcare professionals, and students engaged in these dynamic fields.

SEMINARS IN NEPHROLOGY, published by W B SAUNDERS CO-ELSEVIER INC, stands as a premier journal in the field of nephrology, with a notable impact factor in its category. With its dedicated scope spanning significant developments from 1981 to 2024, this journal provides an essential platform for researchers, clinicians, and students to explore critical advances in renal medicine. Noteworthy for its classification in the Q1 quartile of nephrology journals, SEMINARS IN NEPHROLOGY ranks #18 out of 81 in Scopus, placing it in the 78th percentile of its field, which underscores its influence and contribution to contemporary research. While it currently does not offer open access, the journal remains a vital resource for anyone seeking to deepen their understanding of nephrological advancements and complexities. With an established address located at 1600 John F. Kennedy Boulevard, Ste 1800, Philadelphia, PA 19103-2899, it continues to draw a global readership committed to the pursuit of knowledge in kidney health and disease.

Kidney International Reports, published by ELSEVIER SCIENCE INC, stands as a premier open-access journal in the realm of nephrology, having established itself since its inception in 2016. This scholarly platform, with an ISSN of 2468-0249, is dedicated to presenting high-quality research and critical reviews that advance our understanding of kidney health and disease. With a remarkable Q1 ranking in nephrology and a notable position within the top 10 of Scopus rankings for this specialty, the journal is a pivotal resource for researchers, healthcare professionals, and students alike. Featuring a broad scope of topics from clinical nephrology to innovative treatment strategies, Kidney International Reports ensures accessibility to the latest findings through its open access model, making it instrumental in promoting knowledge sharing and collaboration across the global nephrology community. The journal's commitment to excellence not only enhances the visibility of research but also fosters the development of effective treatments and therapies for kidney diseases.

NEPHROLOGY is a leading academic journal published by Wiley, dedicated to advancing research and discussions in the fields of Nephrology and Medicine. With an ISSN of 1320-5358, this journal has consistently demonstrated its significance and impact, reflecting a Q2 category ranking in both Medicine (miscellaneous) and Nephrology as of 2023. Covering a comprehensive range of topics since its inception in 1995, NEPHROLOGY provides a vital platform for researchers, practitioners, and students alike to explore the latest advancements, innovative treatments, and diverse challenges within the field. Although it does not operate under an open access model, the journal remains highly regarded, with a commendable Scopus rank of #27 out of 81 in Nephrology, positioning it in the 67th percentile among its peers. Located in the United Kingdom, NEPHROLOGY invites submissions that push the boundaries of knowledge, ultimately striving to enhance the understanding of renal health and disease.

CLINICAL NEPHROLOGY is a prestigious academic journal dedicated to advancing the field of nephrology and related areas of medicine. Published by DUSTRI-VERLAG DR KARL FEISTLE, this journal has been a critical resource for researchers and practitioners since its inception in 1973, with a commitment to disseminating high-quality, peer-reviewed articles that provide insights into clinical practices, innovative treatments, and emerging research in kidney diseases. With an ISSN of 0301-0430, CLINICAL NEPHROLOGY stands out in the medical community, achieving a commendable Q3 ranking in both general medicine and nephrology fields as of 2023. The journal's focus on both clinical application and rigorous scientific inquiry makes it an essential read for healthcare professionals and researchers looking to stay at the forefront of nephrology advancements. Although it operates under a subscription model, its broad scope promises invaluable contributions that address practical challenges and foster interdisciplinary dialogue within the healthcare landscape.

KIDNEY INTERNATIONAL is a leading journal in the field of nephrology, published by Elsevier Science Inc, renowned for its rigorous peer-review process and high-quality research contributions. Established in 1972, this distinguished journal serves as a vital platform for disseminating groundbreaking findings and innovative methodologies that advance the understanding and treatment of kidney-related conditions. With an impressive impact factor reflected in its Q1 category ranking in nephrology and a high Scopus rank of #3 out of 81, it comfortably sits in the top tier of academic literature. Although it offers traditional subscription access, KIDNEY INTERNATIONAL maintains its reputation for excellence by engaging an audience of researchers, healthcare professionals, and students dedicated to improving renal health. The journal is committed to publishing articles that address pressing challenges in nephrology, making it an essential resource for those seeking to enhance their knowledge and practice in the field.

RENAL FAILURE is a distinguished academic journal published by TAYLOR & FRANCIS LTD, focusing on pivotal research in the fields of nephrology, critical care, and intensive care medicine. With an impact factor reflecting its significant contribution to the medical community, this open access journal has been providing a platform for peer-reviewed articles since its inception, offering free visibility to cutting-edge research since 2016. Based in the United Kingdom, RENAL FAILURE is essential for professionals, researchers, and students who seek to stay informed about the latest advancements and clinical practices in renal care. The journal’s Scopus ranking places it among the top-tier publications in its category, boasting a Q2 ranking in critical care, general medicine, and nephrology, underscoring its impactfulness in the global research landscape. Catering to a wide audience, it spans literature from 1976 through 2024, making it a cornerstone resource for anyone dedicated to enhancing the understanding and treatment of renal diseases.